Frimodt-Møller, Marie http://orcid.org/0000-0002-8486-1515
Hansen, Tine W.
Rasmussen, Daniel G. K.
Theilade, Simone
Nielsen, Signe H.
Karsdal, Morten A.
Genovese, Federica
Rossing, Peter
Article History
Received: 12 December 2018
Accepted: 13 February 2019
First Online: 9 March 2019
Compliance with ethical standards
:
: DGKR, SHN, MAK, and FG are full-time employees of Nordic Bioscience. Nordic Bioscience is a privately owned, small- to medium-sized enterprise partly focused on the development of biomarkers. None of the authors received fees, bonuses, or other benefits for the work described in the article. MAK and FG hold stocks in Nordic Bioscience. The patent for the ELISAs used to measure PRO-C6 and C3M levels is owned by Nordic Bioscience. The funder provided support in the form of salaries for DGKR, SHN, MAK, and FG but did not play any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no conflicts of interest to disclose for PR, ST, TWH or MF.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.